Cardiac 123I-mIBG scintigraphy for prediction of catheter ablation outcome in patients with atrial fibrillation

被引:2
|
作者
Sazonova, S. I. [1 ]
Varlamova, J. V. [1 ]
Nikitin, N. A. [2 ]
Minin, S. M. [2 ]
Kisteneva, I. V. [1 ]
Batalov, R. E. [1 ]
Mishkina, A. I. [1 ]
Ilushenkova, Y. N. [1 ]
Zavadovsky, K. V. [1 ]
Popov, S. V. [1 ]
Romanov, A. B. [2 ]
机构
[1] Russian Acad Sci, Cardiol Res Inst, Tomsk NRMC, Cardiol Res Inst,Tomsk Natl Res Med Ctr, Tomsk, Russia
[2] Minist Hlth Russian Federat, E Meshalkin Natl Med Res Ctr, Novosibirsk, Russia
基金
俄罗斯科学基金会;
关键词
atrial fibrillation; catheter ablation; cardiac innervation; scintigraphy; I-123-mIBG; prognosis; AUTONOMIC NERVOUS-SYSTEM; SPECT; ARRHYTHMIAS;
D O I
10.1007/s12350-021-02658-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Previous studies show inconsistent results on the role of innervation imaging (with I-123-mIBG) in predicting late atrial fibrillation (AF) recurrence after catheter ablation (CA). These studies included patients with paroxysmal AF and studied prognostic value of post-CA I-123-mIBG parameters. Current study investigated the ability of pre CA 123-I-mIBG imaging to predict late AF recurrence in patients with persistent AF. Methods I-123-mIBG cardiac imaging was performed before CA in 82 patients with persistent AF. Patient was followed for 12 months. Results Multivariable analysis demonstrated that late heart-to-mediastinum ratio (H/M-late) and washout rate (WR) were independent predictors of AF recurrence. ROC-curve analysis data showed that H/M-late <1.6 (sensitivity 73.53%, specificity 81.3%, AUC 0.792, P < .001) and WR > 25.11 (sensitivity 70.6%, specificity 70.8.3%, AUC 0.712, P < .001) indicate high probability of AF relapses during 12 months after CA. Conclusion Pre-CA parameters of global cardiac sympathetic activity estimated by I-123-mIBG scintigraphy are associated with late AF relapses in persistent AF patients with normal LVEF and absence of significant CAD.
引用
收藏
页码:2220 / 2231
页数:12
相关论文
共 50 条
  • [21] Reproducibility of the Measurement of Cardiac Sympathetic Innervation by 123I-MIBG Scintigraphy in Patients with Heart Failure
    Garcia-Talavera, P.
    Sainz-Esteban, A.
    Olmos, R.
    Ruiz, M. A.
    Gonzalez, M. L.
    Mota, P.
    Gamazo, C.
    Gomez, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S194 - S194
  • [22] Diagnostic value of cardiac 123I-MIBG scintigraphy in Lewy body disorders
    Minguez-Castellanos, A.
    Escamilla-Sevilla, F.
    Perez-Navarro, M. J.
    Munoz-Pasadas, M.
    Pinana-Plaza, C.
    Gallego-Peinado, M.
    Cabello-Garcia, D.
    Rebollo-Aguirre, A. C.
    Gomez-Rio, M.
    Carnero-Pardo, C.
    Ortega-Moreno, A.
    MOVEMENT DISORDERS, 2008, 23 (01) : S57 - S57
  • [23] Routine preoperative 123I-MIBG scintigraphy for patients with phaeochromocytoma is not necessary
    Radu Mihai
    Fergus Gleeson
    Derek Roskell
    Andrew Parker
    Greg Sadler
    Langenbeck's Archives of Surgery, 2008, 393
  • [24] Assessment of cardiac sympathetic innervations by 123I-MIBG myocardial scintigraphy in patients with neurocardiogenic syncope
    Al'bitskaya, X.
    Pevzner, A.
    Kuchinskaya, E.
    Kheimetz, G.
    Rogoza, A.
    Golitsyn, S.
    Samoylenko, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S73 - S73
  • [25] 123I-MIBG myocardial scintigraphy in overtraining syndrome
    Camacho, Valle
    Estorch, Montserrat
    Serra-Grima, Ricard
    REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (07): : 748 - 749
  • [26] Myocardial 123I-MIBG scintigraphy in patients with PSP, CBD and MSA
    Kenichi Kashihara
    Mitsutoshi Yamamoto
    Journal of Neurology, 2006, 253 : iii35 - iii40
  • [27] The role of 123I-MIBG scintigraphy in pheochromocytoma and paraganglioma
    Saedon, Mahmud
    Parks, Ruth
    Chadwick, David
    BRITISH JOURNAL OF SURGERY, 2019, 106 : 20 - 20
  • [28] Is 123I-MIBG cardiac scintigraphy a surrogate marker for Parkinson's disease?
    Fukuyama, Hidenao
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (01) : 1 - 2
  • [29] Is 123I-MIBG cardiac scintigraphy a surrogate marker for Parkinson’s disease?
    Hidenao Fukuyama
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1 - 2
  • [30] Cardiac 123I-mIBG scintigraphy as a tool to optimize CRT patient selection
    Verschure, D. O.
    Poel, E.
    Frantellizzi, V.
    De Vincentis, G.
    Gheysens, O.
    de Groot, J. R.
    Verberne, H. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S101 - S102